Coral Laboratories revenue rises 91%, profit gains 46% in September

Coral Laboratories Limited reported revenue from operations of Rs 36.37 crore for the quarter ended September 30, 2026, a 91% increase from Rs 19.03 crore a year earlier, while profit for the period rose 46% to Rs 8.49 crore. The unaudited standalone results were approved by the board on November 14, 2026.

How much did Coral Laboratories’ September-quarter revenue grow?

Coral Laboratories’ revenue from operations rose to Rs 36.37 crore in the quarter ended September 30, 2026, from Rs 19.03 crore in the quarter ended September 30, 2025. That Rs 17.33 crore increase equates to about 91%, supporting the rise in reported total income to Rs 38.61 crore from Rs 21.74 crore.

Revenue also increased from Rs 29.62 crore in the preceding quarter ended June 30, 2026. The sequential gain was Rs 6.75 crore, or about 23%, while other income moved to Rs 2.24 crore from Rs 2.15 crore in the June quarter and was below Rs 2.71 crore in the year-earlier quarter.

For the half year ended September 30, 2026, Coral Laboratories reported revenue from operations of Rs 65.99 crore, compared with Rs 37.86 crore in the corresponding half year ended September 30, 2025. Total income for the six-month period rose to Rs 70.39 crore from Rs 42.61 crore, although other income declined to Rs 4.40 crore from Rs 4.76 crore.

Why did Coral Laboratories’ profit rise more slowly than revenue?

Coral Laboratories’ profit for the September 2026 quarter rose to Rs 8.49 crore from Rs 5.82 crore a year earlier, an increase of about 46%, which was slower than the 91% growth in operating revenue. Total expenses climbed to Rs 27.72 crore from Rs 14.65 crore, an increase of about 89%, absorbing much of the additional income.

Material-consumption cost more than doubled to Rs 16.12 crore from Rs 7.31 crore in the year-earlier quarter. Other expenses increased to Rs 6.09 crore from Rs 2.85 crore, while employee-benefit expense rose to Rs 5.00 crore from Rs 3.70 crore and depreciation and amortisation increased to Rs 64.04 lakh from Rs 45.22 lakh.

Profit from operations before exceptional items and tax nevertheless increased to Rs 10.89 crore in the September 2026 quarter from Rs 7.09 crore in the September 2025 quarter. The earlier quarter included an exceptional Rs 32.25 lakh provision for income tax of an earlier year, while the September 2026 quarter reported no exceptional item.

On a sequential basis, profit for the period increased from Rs 5.39 crore in the June 2026 quarter to Rs 8.49 crore in the September quarter. Total expenses rose by Rs 2.89 crore from Rs 24.83 crore, but total income grew by Rs 6.84 crore from Rs 31.77 crore, resulting in a Rs 3.95 crore rise in profit before tax to Rs 10.89 crore.

What were Coral Laboratories’ half-year earnings and per-share results?

Coral Laboratories’ profit for the half year ended September 30, 2026 rose to Rs 13.88 crore from Rs 8.38 crore in the corresponding 2025 period, an increase of about 66%. Profit before tax increased to Rs 17.83 crore from Rs 11.13 crore, while current tax expense rose to Rs 3.95 crore from Rs 2.74 crore.

The company reported basic and diluted earnings per share, or EPS, of Rs 38.84 for the half year, compared with Rs 23.46 in the prior-year half. For the September quarter alone, basic and diluted EPS were Rs 23.76, compared with Rs 16.29 a year earlier and Rs 15.08 in the June 2026 quarter.

Total comprehensive income reached Rs 17.85 crore for the half year ended September 30, 2026, compared with Rs 11.88 crore a year earlier. This was higher than reported period profit because other comprehensive income was Rs 3.97 crore in the latest half year, compared with Rs 3.50 crore in the prior-year period.

What does Coral Laboratories’ balance sheet and cash flow show?

Coral Laboratories reported total assets of Rs 275.69 crore as of September 30, 2026, compared with Rs 240.66 crore as of March 31, 2026. Total equity increased to Rs 226.25 crore from Rs 209.11 crore, including other equity of Rs 222.67 crore versus Rs 205.54 crore at the March year-end.

Trade receivables increased to Rs 42.13 crore at September 30 from Rs 29.43 crore at March 31, while inventories rose to Rs 21.38 crore from Rs 20.53 crore. Current borrowings increased to Rs 13.07 crore from Rs 4.33 crore, and total current liabilities increased to Rs 45.35 crore from Rs 27.31 crore.

Net cash flow from operating activities was an outflow of Rs 8.03 crore in the half year ended September 30, 2026, compared with an inflow of Rs 12.58 crore in the previous-year half. The statement recorded a Rs 12.70 crore increase in trade receivables and a Rs 8.21 crore increase in other assets as working-capital outflows.

Financing activities generated Rs 8.71 crore in the 2026 half year, compared with an outflow of Rs 2.89 crore a year earlier, mainly reflecting Rs 8.77 crore from acceptance or repayment of borrowings and loans. Cash and cash equivalents ended the period at Rs 1.61 crore, compared with Rs 1.37 crore at the beginning of the financial year.

Which business segment reported these results?

Coral Laboratories reported that it has one segment, Formulations, under Indian Accounting Standard 108, or Ind AS 108. The September-quarter revenue of Rs 36.37 crore and half-year revenue of Rs 65.99 crore therefore represent the company’s sole disclosed operating segment rather than a combination of separately reported business divisions.

The results are standalone and unaudited for the quarter and half year ended September 30, 2026. Coral Laboratories said its statutory auditors carried out a limited review, while the audit committee reviewed the results before board approval on November 14, 2026.

The filing also reported no investor complaints at the beginning of, received during, disposed of during, or pending at the end of the September 2026 quarter. The paid-up equity share capital remained Rs 3.57 crore, based on shares with a face value of Rs 10 each.

Conclusion

Coral Laboratories delivered substantially higher September-quarter sales, with revenue from operations rising 91% year on year to Rs 36.37 crore and period profit increasing 46% to Rs 8.49 crore. The difference in growth rates reflects an increase in expenses to Rs 27.72 crore, particularly materials, employee costs and other expenses, even as profit before tax rose to Rs 10.89 crore.

The next reporting period will show whether revenue growth is sustained while trade receivables, which reached Rs 42.13 crore at September 30, and operating cash flow, which was an outflow of Rs 8.03 crore for the half year, change.